Top

Published in:

01-04-2022 | Magnetic Resonance Imaging | Review Article

Neurological side effects of radiation therapy

Authors: J. Jacob, L. Feuvret, J.-M. Simon, M. Ribeiro, L. Nichelli, C. Jenny, D. Ricard, D. Psimaras, K. Hoang-Xuan, P. Maingon

Published in: Neurological Sciences | Issue 4/2022

Abstract

Radiation therapy (RT) is one of the main treatments administered to patients with cancer. The development of technology has improved RT accuracy by allowing more precise delivery of high doses to the target volumes with reduced exposure of healthy tissue. Life expectancy has increased due to these therapeutic advancements and the patients’ quality of life remains a major concern. The adverse events related to RT are quite various and most likely will impair essential neurological functions, e.g. cognitive status. This literature review aims to describe the physiopathological processes, the neurological symptoms as well as the local modifications observed in magnetic resonance imaging following RT. The specific therapeutic options and preventive actions will also be discussed.

Saad S, Wang TJ (2015) Neurocognitive deficits after radiation therapy for brain malignancies. Am J Clin Oncol 38:634–640. https://doi.org/10.1097/COC.0000000000000158CrossRefPubMed

International Agency for Research on Cancer (2021) Cancer Today. Estimated number of new cases in 2020, worldwide, both sexes, all ages. World Health Organization. https://gco.iarc.fr/today/online-analysis-table. Accessed 12 Nov 2021

Borras JM, Lievens Y, Barton M et al (2016) How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol 119:5–11. https://doi.org/10.1016/j.radonc.2016.02.016CrossRefPubMed

Greene-Schloesser D, Moore E, Robbins ME (2013) Molecular pathways: radiation-induced cognitive impairment. Clin Cancer Res 19:2294–2300. https://doi.org/10.1158/1078-0432.CCR-11-2903CrossRefPubMedPubMedCentral

Makale MT, McDonald CR, Hattangadi-Gluth JA et al (2017) Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol 13:52–64. https://doi.org/10.1038/nrneurol.2016.185CrossRefPubMed

Terziev R, Psimaras D, Marie Y et al (2021) Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors. Sci Rep 11:10176. https://doi.org/10.1038/s41598-021-89216-1CrossRefPubMedPubMedCentral

Ellingson BM, Chung C, Pope WB et al (2017) Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol 134:495–504. https://doi.org/10.1007/s11060-017-2375-2CrossRefPubMedPubMedCentral

Lumniczky K, Szatmári T, Sáfrány G (2017) Ionizing radiation-induced immune and inflammatory reactions in the brain. Front Immunol 8:517. https://doi.org/10.3389/fimmu.2017.00517CrossRefPubMedPubMedCentral

Li YQ, Chen P, Haimovitz-Friedman A et al (2003) Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res 63:5950–5956PubMed

10.

Brown WR, Thore CR, Moody DM et al (2005) Vascular damage after fractionated whole-brain irradiation in rats. Radiat Res 164:662–668. https://doi.org/10.1667/rr3453.1CrossRefPubMed

11.

Ruben JD, Dally M, Bailey M et al (2006) Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 65:499–508. https://doi.org/10.1016/j.ijrobp.2005.12.002CrossRefPubMed

12.

IJzerman-Korevaar M, Snijders TJ, de Graeff A, et al (2018) Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol 140:485–496. https://doi.org/10.1007/s11060-018-03015-9CrossRef

13.

Le Guyader M, Antoni D (2021) Under-recognized toxicities of cranial irradiation. Cancer Radiother 25:713–722. https://doi.org/10.1016/j.canrad.2021.06.019CrossRefPubMed

14.

Harjani RR, Gururajachar JM, Krishnaswamy U (2016) Comprehensive assessment of somnolence syndrome in patients undergoing radiation to the brain. Rep Pract Oncol Radiother 21:560–566. https://doi.org/10.1016/j.rpor.2016.08.003CrossRefPubMedPubMedCentral

15.

Douw L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810–818. https://doi.org/10.1016/S1474-4422(09)70204-2CrossRefPubMed

16.

Brown PD, Jensen AW, Felten SJ et al (2006) Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 24:5427–5433. https://doi.org/10.1200/JCO.2006.08.5605CrossRefPubMed

17.

Klein M (2016) Lesion momentum as explanation for preoperative neurocognitive function in patients with malignant glioma. Neuro Oncol 18:1595–1596. https://doi.org/10.1093/neuonc/now266CrossRefPubMedPubMedCentral

18.

Karunamuni R, Tringale KR, Burkeen J et al (2020) Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial. J Neurooncol 146:131–138. https://doi.org/10.1007/s11060-019-03353-2CrossRefPubMed

19.

Soussain C, Ricard D, Fike JR et al (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639–1651. https://doi.org/10.1016/S0140-6736(09)61299-XCrossRefPubMed

20.

Bompaire F, Lahutte M, Buffat S et al (2018) New insights in radiation-induced leukoencephalopathy: a prospective cross-sectional study. Support Care Cancer 26:4217–4226. https://doi.org/10.1007/s00520-018-4296-9CrossRefPubMed

21.

Jacob J, Durand T, Feuvret L et al (2018) (2018) Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review. Radiother Oncol 128:221–228. https://doi.org/10.1016/j.radonc.2018.05.027CrossRefPubMed

22.

Durand T, Jacob S, Lebouil L et al (2015) EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. BMC Neurol 15:261. https://doi.org/10.1186/s12883-015-0519-6CrossRefPubMedPubMedCentral

23.

Nordal RA, Nagy A, Pintilie M et al (2004) Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res 10:3342–3353. https://doi.org/10.1158/1078-0432.CCR-03-0426CrossRefPubMed

24.

Chao ST, Ahluwalia MS, Barnett GH et al (2013) Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys 87:449–457. https://doi.org/10.1016/j.ijrobp.2013.05.015CrossRefPubMed

25.

Noël G, Antoni D (2021) Organs at risk radiation dose constraints. Cancer Radiother S1278–3218(21):00272–00279. https://doi.org/10.1016/j.canrad.2021.11.001CrossRef

26.

Patel UK, Patel K, Malik P et al (2020) Stroke-like migraine attacks after radiation therapy (SMART) syndrome-a case series and review. Neurol Sci 41:3123–3134. https://doi.org/10.1007/s10072-020-04586-0CrossRefPubMed

27.

Black DF, Bartleson JD, Bell ML et al (2006) SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia 26:1137–1142. https://doi.org/10.1111/j.1468-2982.2006.01184.xCrossRefPubMed

28.

Rheims S, Ricard D, van den Bent M et al (2011) Peri-ictal pseudoprogression in patients with brain tumor. Neuro Oncol 13:775–782. https://doi.org/10.1093/neuonc/nor082CrossRefPubMedPubMedCentral

29.

Di Stefano AL, Berzero G, Vitali P et al (2013) Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication. Neurology 81:1014–1017. https://doi.org/10.1212/WNL.0b013e3182a43b1fCrossRefPubMed

30.

Alemany M, Velasco R, Simó M et al (2020) Late effects of cancer treatment: consequences for long-term brain cancer survivors. Neurooncol Pract 8:18–30. https://doi.org/10.1093/nop/npaa039CrossRefPubMedPubMedCentral

31.

Di Stefano AL, Berzero G, Ducray F et al (2019) Stroke-like events after brain radiotherapy: a large series with long-term follow-up. Eur J Neurol 26:639–650. https://doi.org/10.1111/ene.13870CrossRefPubMed

32.

Murphy ES, Xie H, Merchant TE et al (2015) Review of cranial radiotherapy-induced vasculopathy. J Neurooncol 122:421–429. https://doi.org/10.1007/s11060-015-1732-2CrossRefPubMed

33.

Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226–1237. https://doi.org/10.1056/NEJMra0804622CrossRefPubMed

34.

Tabrizi S, Yeap BY, Sherman JC et al (2019) Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol 137:95–101. https://doi.org/10.1016/j.radonc.2019.04.027CrossRefPubMedPubMedCentral

35.

Li PC, Liebsch NJ, Niemierko A et al (2019) Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy. Radiother Oncol 131:112–119. https://doi.org/10.1016/j.radonc.2018.12.007CrossRefPubMed

36.

D’Elia A, Tropeano MP, Maiola V et al (2015) The etiology of low-grade gliomas: pathological and clinical considerations about radiation-induced low-grade gliomas. Neurol Sci 36:1091–1095. https://doi.org/10.1007/s10072-015-2136-yCrossRefPubMed

37.

Connor M, Karunamuni R, McDonald C et al (2016) Dose-dependent white matter damage after brain radiotherapy. Radiother Oncol 121:209–216. https://doi.org/10.1016/j.radonc.2016.10.003CrossRefPubMedPubMedCentral

38.

Zhu T, Chapman CH, Tsien C et al (2016) Effect of the maximum dose on white matter fiber bundles using longitudinal diffusion tensor imaging. Int J Radiat Oncol Biol Phys 96:696–705. https://doi.org/10.1016/j.ijrobp.2016.07.010CrossRefPubMedPubMedCentral

39.

Connor M, Karunamuni R, McDonald C et al (2017) Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol 123:209–217. https://doi.org/10.1016/j.radonc.2017.04.006CrossRefPubMedPubMedCentral

40.

Tringale KR, Nguyen T, Bahrami N et al (2019) Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: a prospective clinical trial in primary brain tumor patients. Radiother Oncol 132:27–33. https://doi.org/10.1016/j.radonc.2018.11.018CrossRefPubMed

41.

Le Fèvre C, Lhermitte B, Ahle G et al (2021) Pseudoprogression versus true progression in glioblastoma patients: a multiapproach literature review: Part 1 - Molecular, morphological and clinical features. Crit Rev Oncol Hematol 157:103188. https://doi.org/10.1016/j.critrevonc.2020.103188CrossRefPubMed

42.

Nichelli L, Casagranda S (2021) Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis. Curr Opin Oncol 33:597–607. https://doi.org/10.1097/CCO.0000000000000793CrossRefPubMedPubMedCentral

43.

Cuccurullo V, Di Stasio GD, Cascini GL et al (2019) The molecular effects of ionizing radiations on brain cells: radiation necrosis vs. tumor recurrence. Diagnostics 9:127. https://doi.org/10.3390/diagnostics9040127

44.

Kłos J, van Laar PJ, Sinnige PF et al (2019) Quantifying effects of radiotherapy-induced microvascular injury; review of established and emerging brain MRI techniques. Radiother Oncol 140:41–53. https://doi.org/10.1016/j.radonc.2019.05.020CrossRefPubMed

45.

Stone JB, DeAngelis LM (2016) Cancer-treatment-induced neurotoxicity–focus on newer treatments. Nat Rev Clin Oncol 13:92–105. https://doi.org/10.1038/nrclinonc.2015.152CrossRefPubMed

46.

Moretti R, Caruso P (2020) an iatrogenic model of brain small-vessel disease: post-radiation encephalopathy. Int J Mol Sci 21:6506. https://doi.org/10.3390/ijms21186506CrossRefPubMedCentral

47.

Levin VA, Bidaut L, Hou P et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79:1487–1495. https://doi.org/10.1016/j.ijrobp.2009.12.061CrossRefPubMedPubMedCentral

48.

Chung C, Bryant A, Brown PD (2018) Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Cochrane Database Syst Rev 7:CD011492. https://doi.org/10.1002/14651858.CD011492.pub2

49.

Gehring K, Sitskoorn MM, Gundy CM et al (2009) Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 27:3712–3722. https://doi.org/10.1200/JCO.2008.20.5765CrossRefPubMed

50.

Chi D, Behin A, Delattre J-Y (2008) Neurologic complications of radiation therapy. In: Schiff D, Kesari S, Wen PY (eds) Cancer Neurology in Clinical Practice. Humana Press, New Jersey, pp 259–286CrossRef

51.

Ko HC, Powers AR, Sheu RD et al (2015) Lhermitte’s sign following VMAT-based head and neck radiation-insights into mechanism. PLoS ONE 10:e0139448. https://doi.org/10.1371/journal.pone.0139448CrossRefPubMedPubMedCentral

52.

Peyraga G, Ducassou A, Arnaud FX et al (2021) Radiothérapie et toxicité médullaire : actualités et perspectives [Radiotherapy and spinal toxicity: News and perspectives]. Cancer Radiother 25:55–61. https://doi.org/10.1016/j.canrad.2020.05.017CrossRefPubMed

53.

Giglio P, Gilbert MR (2010) Neurologic complications of cancer and its treatment. Curr Oncol Rep 12:50–59. https://doi.org/10.1007/s11912-009-0071-xCrossRefPubMedPubMedCentral

54.

Khan M, Ambady P, Kimbrough D et al (2018) Radiation-induced myelitis: initial and follow-up MRI and clinical features in patients at a single tertiary care institution during 20 years. AJNR Am J Neuroradiol 39:1576–1581. https://doi.org/10.3174/ajnr.A5671CrossRefPubMedPubMedCentral

55.

Silvestro S, Bramanti P, Trubiani O et al (2020) Stem cells therapy for spinal cord injury: an overview of clinical trials. Int J Mol Sci 21:659. https://doi.org/10.3390/ijms21020659CrossRefPubMedCentral

56.

Rubin DI (2020) Brachial and lumbosacral plexopathies: a review. Clin Neurophysiol Pract 5:173–193. https://doi.org/10.1016/j.cnp.2020.07.005CrossRefPubMedPubMedCentral

57.

Yan M, Kong W, Kerr A et al (2019) The radiation dose tolerance of the brachial plexus: a systematic review and meta-analysis. Clin Transl Radiat Oncol 18:23–31. https://doi.org/10.1016/j.ctro.2019.06.006CrossRefPubMedPubMedCentral

58.

Hoeller U, Bonacker M, Bajrovic A et al (2004) Radiation-induced plexopathy and fibrosis. is magnetic resonance imaging the adequate diagnostic tool? Strahlenther Onkol 180:650–654. https://doi.org/10.1007/s00066-004-1240-3CrossRefPubMed

59.

Jordan B, Margulies A, Cardoso F et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31:1306–1319. https://doi.org/10.1016/j.annonc.2020.07.003CrossRefPubMed

60.

Kazda T, Jancalek R, Pospisil P et al (2014) Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol 9:139. https://doi.org/10.1186/1748-717X-9-139CrossRefPubMedPubMedCentral

61.

Ma TM, Grimm J, McIntyre R et al (2017) A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation. Radiother Oncol 125:234–240. https://doi.org/10.1016/j.radonc.2017.09.035CrossRefPubMed

62.

Karunamuni RA, Moore KL, Seibert TM et al (2016) Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiother Oncol 118:29–34. https://doi.org/10.1016/j.radonc.2016.01.003CrossRefPubMedPubMedCentral

63.

Shih HA, Sherman JC, Nachtigall LB et al (2015) Proton therapy for low-grade gliomas: results from a prospective trial. Cancer 121:1712–1719. https://doi.org/10.1002/cncr.29237CrossRefPubMed

64.

Jalali R, Gupta T, Goda JS et al (2017) Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and low-grade brain tumors: a randomized clinical trial. JAMA Oncol 3:1368–1376. https://doi.org/10.1001/jamaoncol.2017.0997CrossRefPubMedPubMedCentral

65.

Ruschin M, Sahgal A, Tseng CL et al (2017) Dosimetric impact of using a virtual couch shift for online correction of setup errors for brain patients on an integrated high-field magnetic resonance imaging linear accelerator. Int J Radiat Oncol Biol Phys 98:699–708. https://doi.org/10.1016/j.ijrobp.2017.03.004CrossRefPubMed

66.

Chaddad A, Kucharczyk MJ, Daniel P et al (2019) radiomics in glioblastoma: current status and challenges facing clinical implementation. Front Oncol 9:374. https://doi.org/10.3389/fonc.2019.00374CrossRefPubMedPubMedCentral

67.

Montay-Gruel P, Acharya MM, Gonçalves Jorge P et al (2021) Hypofractionated FLASH-RT as an effective treatment against glioblastoma that reduces neurocognitive side effects in mice. Clin Cancer Res 27:775–784. https://doi.org/10.1158/1078-0432.CCR-20-0894CrossRefPubMed

68.

Correa DD, Satagopan J, Baser RE et al (2014) APOE polymorphisms and cognitive functions in patients with brain tumors. Neurology 83:320–327. https://doi.org/10.1212/WNL.0000000000000617CrossRefPubMedPubMedCentral

69.

Brown PD, Pugh S, Laack NN et al (2013) Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 15:1429–1437. https://doi.org/10.1093/neuonc/not114CrossRefPubMedPubMedCentral

70.

Rapp SR, Case LD, Peiffer A et al (2015) Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol 33:1653–1659. https://doi.org/10.1200/JCO.2014.58.4508CrossRefPubMedPubMedCentral

Title: Neurological side effects of radiation therapy
Authors: J. Jacob
L. Feuvret
J.-M. Simon
M. Ribeiro
L. Nichelli
C. Jenny
D. Ricard
D. Psimaras
K. Hoang-Xuan
P. Maingon
Publication date: 01-04-2022
Publisher: Springer International Publishing
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Antiepileptic Drugs
Antiepileptic Drugs
Published in: Neurological Sciences / Issue 4/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-05944-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neurological side effects of radiation therapy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2022

Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls

Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements

Construction of a nomogram to reveal the prognostic benefit of spontaneous intracranial hemorrhage among Chinese adults: a population-based study

In-hospital and out-of-hospital stroke in patients with COVID-19: two different diseases?

Neurophysiological and ultrasonographic comparative study of autonomous nervous system in patients suffering from fibromyalgia and generalized anxiety disorder

Correction to: Effects of cognitive rehabilitation in Parkinson disease: a metaanalysis